A Phase 2 Study of the Effects of 6R-BH4 in Subjects With Sickle Cell Disease

Clinical trial NCT00445978 · COMPLETED

Trial details

NCT number: NCT00445978
Sponsor: BioMarin Pharmaceutical
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2007-05-01
Primary completion: 2008-08-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.